1.40
전일 마감가:
$1.42
열려 있는:
$1.4
하루 거래량:
154.73K
Relative Volume:
0.55
시가총액:
$72.73M
수익:
-
순이익/손실:
$-51.47M
주가수익비율:
-1.40
EPS:
-1
순현금흐름:
$-47.50M
1주 성능:
-0.71%
1개월 성능:
+33.33%
6개월 성능:
-1.41%
1년 성능:
-11.95%
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
명칭
Pmv Pharmaceuticals Inc
전화
(609) 642-6670
주소
400 ALEXANDER PARK DRIVE, PRINCETON
PMVP을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
PMVP
Pmv Pharmaceuticals Inc
|
1.40 | 73.77M | 0 | -51.47M | -47.50M | -1.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-11-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
2024-05-13 | 개시 | Craig Hallum | Buy |
2024-04-12 | 개시 | Jefferies | Buy |
2023-12-27 | 개시 | Ladenburg Thalmann | Buy |
2022-03-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
2021-09-22 | 업그레이드 | Goldman | Neutral → Buy |
2021-08-19 | 개시 | Oppenheimer | Perform |
2021-08-02 | 개시 | Guggenheim | Buy |
2021-07-29 | 개시 | H.C. Wainwright | Buy |
2020-10-20 | 개시 | BofA Securities | Buy |
2020-10-20 | 개시 | Cowen | Outperform |
2020-10-20 | 개시 | Evercore ISI | Outperform |
2020-10-20 | 개시 | Goldman | Neutral |
모두보기
Pmv Pharmaceuticals Inc 주식(PMVP)의 최신 뉴스
Is PMV Pharmaceuticals Inc. a growth stock or a value stockCapitalize on fast-moving stock trends - jammulinksnews.com
Will PMV Pharmaceuticals Inc. rebound enough to break evenFree Daily Picks With Predictable Performance - Newser
Visual analytics tools that track PMV Pharmaceuticals Inc. performanceWeekly Price Target Forecast and Alerts - Newser
How to integrate PMV Pharmaceuticals Inc. into portfolio analysis toolsChart Driven Entry Timing for Swing Trades - Newser
How does PMV Pharmaceuticals Inc. compare to its industry peersPost Market Opportunities With High Returns - jammulinksnews.com
What MACD and RSI say about PMV Pharmaceuticals Inc.Real-Time Equity Price Action Analysis - Newser
Is PMV Pharmaceuticals Inc. a candidate for recovery playBuy Point Strategy with Profit Protection - Newser
Is a relief rally coming for PMV Pharmaceuticals Inc. holdersAI Powered Stock Market Trend Forecast - Newser
How to interpret RSI for PMV Pharmaceuticals Inc. stockEarnings Based Stock Performance Forecast - Newser
How high can PMV Pharmaceuticals Inc. stock goHigh Accuracy Trade Setup Identification - Newser
Should you wait for a breakout in PMV Pharmaceuticals Inc.Free Trade Setups With Clear Risk Limits - Newser
Why PMV Pharmaceuticals Inc. stock attracts strong analyst attentionWeekly Chart Watchlist with Trade Guidance - Newser
Heatmap analysis for PMV Pharmaceuticals Inc. and competitorsReal-Time Entry Signals for Top Stocks - Newser
Published on: 2025-07-30 23:35:44 - metal.it
Risk vs reward if holding onto PMV Pharmaceuticals Inc.Price Action Summary and Entry Strategy Guide - Newser
PMV Pharmaceuticals Inc. Stock Performance After Earnings: Historical InsightsFree Sector Based Breakout Stock Forecast - Newser
Is PMV Pharmaceuticals Inc. forming a reversal patternForecast Model for Intraday Buy Signals - Newser
What to do if you’re stuck in PMV Pharmaceuticals Inc.Weekly Market Direction and Sector Summary - Newser
Published on: 2025-07-30 00:45:41 - Newser
PMV Pharmaceuticals Inc (PMVP Stock: A Sea of Opportunity - investchronicle.com
What does PMVP's flat EPS in 2024 indicate for investors? - AInvest
What makes MetaVia Inc. stock price move sharplyWeekly Outlook for Short Term Investors - Newser
Should I hold or sell PMV Pharmaceuticals Inc. stock in 2025Consistently outstanding ROI - jammulinksnews.com
PMV Pharmaceuticals Inc. Recovers — But Is It SustainableReal-Time Analysis With Entry Targets In Progress - metal.it
How strong is PMV Pharmaceuticals Inc. company’s balance sheetOutperformance with explosive growth - jammulinksnews.com
What makes EOSE stock price move sharplyTechnical Confirmation System with Signal Alerts - Newser
Will MTUL stock recover after recent dropInvestment Life Cycle Planning Summary - Newser
Using data models to predict Angi Inc. stock movementValue Investing Checklist with Entry Signals - Newser
When is PMV Pharmaceuticals Inc. stock expected to show significant growthFree Daily Trading Room Entry - jammulinksnews.com
Why PMV Pharmaceuticals Inc. stock attracts strong analyst attention Watchlist Generator for Smart Money Signals - metal.it
What is IPDN company’s growth strategyTriple-digit returns - jammulinksnews.com
New Product Launches: Will They Boost PMV Pharmaceuticals Inc. Stock in 2025Defensive Stock Picks with Upside - metal.it
What are FURY company’s key revenue driversStrong return on assets - jammulinksnews.com
What are PMV Pharmaceuticals Inc. company’s key revenue driversUncover the best stocks for explosive growth - jammulinksnews.com
What analysts say about PMV Pharmaceuticals Inc. stock outlookAI Powered Stock Call - Newser
Smith Midland Corporation Stock Support and Resistance Levels You Should KnowInvestor Favorite Picks - Newser
Buy Signal for The Hanover Insurance Group Inc. Stock Key Technical Indicators to WatchConsistent Growth Alert - Newser
How Efficient Is MATW at Controlling Operating CostsProven Win Setups - Newser
How Tennant Company stock performs during market volatilityFree Market Dynamics Reports - Newser
Pmv Pharmaceuticals Inc (PMVP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Pmv Pharmaceuticals Inc 주식 (PMVP) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Jalota Deepika | Chief Development Officer |
Jul 01 '25 |
Sale |
1.06 |
33,065 |
35,198 |
89,959 |
Carulli Michael | Chief Financial Officer |
Jul 01 '25 |
Sale |
1.06 |
28,249 |
30,077 |
60,146 |
Mack David Henry | President and CEO |
Jul 01 '25 |
Sale |
1.06 |
58,411 |
62,179 |
536,133 |
Mack David Henry | President and CEO |
Dec 03 '24 |
Option Exercise |
0.53 |
91,750 |
48,628 |
534,210 |
Mack David Henry | President and CEO |
Jan 03 '25 |
Option Exercise |
0.53 |
17,709 |
9,386 |
551,919 |
Jalota Deepika | Chief Development Officer |
Sep 11 '24 |
Sale |
1.50 |
7,218 |
10,853 |
118,283 |
Carulli Michael | Chief Financial Officer |
Sep 11 '24 |
Sale |
1.50 |
2,891 |
4,347 |
88,395 |
자본화:
|
볼륨(24시간):